Inhibition of choriocapillaris regeneration with genistein

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 7, 1999, Pages 1477-1486

  Majji, Ajit B ^a   Hayashi, Atsushi ^a   Kim, Hyung Chan ^a   Grebe, Rhonda R ^a   De Eugene Jr , Juan ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOROID CAPILLARY LAYER; CONTROLLED STUDY; DRUG EFFECT; INTRAVITREAL DRUG ADMINISTRATION; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RABBIT; SUBRETINAL NEOVASCULARIZATION; TISSUE REGENERATION; WOUND HEALING;

ANIMALS; CAPILLARIES; CHOROID; CORROSION CASTING; CYCLOHEXIMIDE; DEBRIDEMENT; ENZYME INHIBITORS; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; GENISTEIN; INJECTIONS; MICROSCOPY, ELECTRON, SCANNING; NEOVASCULARIZATION, PHYSIOLOGIC; PIGMENT EPITHELIUM OF EYE; RABBITS; REGENERATION; WOUND HEALING;

EID: 0033050396     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Macular photocoagulation study group: krypton laser photocoagulation for neovascular lesions of age related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol. 1990;108:816-824.
2. Macular photocoagulation study group: krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Arch Ophthalmol. 1987;105:1499-1507.
3. Macular photocoagulation study group: krypton laser photocoagulation for idiopathic neovascular lesions. Results of a randomized clinical trial. Arch Ophthalmol. 1990;108:832-837.
4. Thomas MA, Dickinson JD, Melberg NS, Ibanez HE, Dhaliwal RS. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology. 1994;101:1384-1396.
5. Berger AS, Kaplan HJ. Clinical experience with the surgical removal of subfoveal neovascular membranes. Ophthalmology. 1992;99:969-976.
6. Sarks SH. Changes in the region of the choriocapillaris in aging and degeneration. In: Shimizu K, Oosterhius J eds. 23rd Concilium Ophthalmologium, Amsterdam. Kyoto, Japan, 1978. Exerpta Medica. 1978:228-238.
7. Gartner S, Henkind P. Pathology of retinitis pigmentosa. Ophthalmology. 1982:89:1425-1432.
8. Miller F, Milam AB, Kalina R. A clinical ultrastnictural study of thioridazine retinopathy. Ophthalmology. 1982;89:1478.
9. Korte GE, Reppucci V, Henkind P. RPE destruction causes choriocapillary atrophy. Invest Ophthalmol Vis Sci. 1984;25:1135-1145.
10. Korte GE, Gerszberg T, Pua F, Henkind V. Choriocapillary atrophy after experimental destruction of retinal pigment epithelium in the rat: a study in thin sections and vascular casts. Acta Anat. 1986; 127:171-175.
11. Korte GE, Pua F. Choriocapillary regeneration in the rabbit: a study with vascular casts. Acta Anat. 1988;133:224-228.
12. Hariot WJ, Machemer R. Pigment epithelial repair. Graefes Arch Clin Exp Ophthalmol. 1992;230:91-100.
13. Del Priore VL, Kaplan HJ, Horbeck R, Jones Z, Swinn M. Retinal pigment epithelial debridement as a model for the pathogenesis and treatment of macular degeneration. Am J Ophthalmol. 1996; 122:629-643.
14. Leonard DS, Zhang XG, Panozzo G, Sugino IK, Zarbin MA. Clinicopathological correlation of localized retinal pigment epithelial debridement. Invest Ophthalmol Vis Sci. 1997;38:1094-1109.
15. Frank RN, Amin RH, Eliott D, Puklin JE, Abrams GW. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol. 1996;122:393-403.
16. Morse LS, Sidikaro Y, Terell J. Retinal pigment epithelium promotes proliferation of choroidal microvessels in vitro [ARVO Abstruct]. Invest Ophthalmol Vis Sci. 1986:27S(4):327.
17. Schweigerer L, Malerstein B, Nenfield G, et al. Basic fibroblast growth factor is synthesized in cultured retinal pigment epithelial cells. Biochem Biophys Res Commun. 1987;143:934-942.
18. Glasser BM, Campochiaro PA, Devis JL, et al. Retinal pigment epithelial cells release an inhibitor of neovascularization. Arch Ophthalmol. 1985;103:1870-1875.
19. Wong HC, Boulton M. Mcleod D, et al. Retinal pigment epithelial cells in culture produce retinal vascular mitogens. Arch Ophthalmol. 1988;106:1439-1443.
20. Eldridge AC. High performance liquid chromatography separation of soybean isoflavones and their glucosides. J Chromatogr. 1982; 234:494-496.
21. Akiyama T, Ishida J Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine specific protein kinases. J Biol Chem. 1987;262: S592-S595.
22. Fotosis T, Pepper M, Adelercrentz H, Hase T, Montesano R, Schweigerer L. Genistein a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr. 1995;125:790S-797S.
23. Steele VE, Pereria MA, Sigman CC, Kelloff GJ. Cancer chemopreventive agent development strategies for genistein. J Nutr. 1995; 125:713S-716S.
24. Popovich K, Gaitan A, de Juan E Jr. Inhibition of protein tyrosine kinase by genistein: a novel approach to the inhibition of growth factor mediated tissue proliferation [ARVO abstract]. Invest Ophthalmol Vis Sci. 1991;32(4):S834.
25. Karoma BM, de Juan E Jr. Phosphotyrosine inhibition and control of vascular endothelial cell proliferation by genistein. Biochem Pharmacol. 1994;48:809-818.
26. Karoma BM, de Juan E Jr. Changes associated with tyrosine phosphorylation during short term hypoxia in retinal microvascular endothelial cells in vitro. J Cell Biochem. 1995;59:123-132.
27. Peterson G. Evaluation of the biochemical targets of genistein in tumor cells. J Nutr. 1995;125:784S-789S.
28. Constantinon A, Kiguchi K, Huberman E. Induction of differentiation and DNA strand breakage in human HLA-60 and K-562 leukemia cells by genistein. Cancer Res. 1990;50:2618-2624.
29. Linassier C, Pierre M, Lepeco JB, Pierre J. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem Pharmacol. 1990;39:187-193.
30. Jha HC, Recklinghausen GV, Zilliken F. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. Biochem Pharmacol. 1985;34:1367-1369.
31. Wei H, Wei L, Frenkel K, Bowen R, Barns S. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer. 1993;20:1-12.
32. Hayashi A, Weinberger AWA, Kim HC, de Juan E Jr. Genistein, a protein tyrosine kinase inhibitor, ameliorates retinal degeneration after ischemia-reperfusion injury in rat. Invest Ophthalmol Vis Sci. 1997;38:1193-1202.
33. + protection of cerebellar granule neurons switched to non-depolarizing medium. Eur J Pharmacol. 1996;315:111-114.
34. Ohh M, Takei F. Regulation of ICAM-1 mRNA stability by cycloheximide: role of serine/threonine phosphorylation and protein synthesis. J Cell Biochem. 1995;59:202-213.
35. Inonye M, Tamaru M, Kameyama y. Effects of cycloheximide and actinomycin D on radiation induced apoptotic cell death in the developing mouse cerebellum. Int J Radiat Biol. 1992;61:669-674.
36. Furusawa S, Nakano S, Kosaka K, Takayanagi M, Takayanagi Y, Sasaki K. Inhibition of doxorubicin-induced cell death in vitro and in vivo by cycloheximide. Biol Pharm Bull. 1995;18:1367-1372.
37. + T cell blasts. Immunol Letts. 1993;35:125-134.
38. Gronowski AM, Stunff CL, Rotweim P. Acute nuclear actions of growth hormone (GH): cycloheximide inhibits inducible activator protein-1 activity, but does not block GH-regulated signal transducer and activator of transcription activation or gene expression. Endocrinology. 1996;137:55-64.
39. Hirasawa N, Kawamura R, Matsui N, et al. inhibition of histamine release from RBL-2H3 cells by protein synthesis inhibitors. Int Arch Allergy Immunol. 1994;103:266-273.
40. Kharlamov E, Cagnoli CM, Atabay C, et al. Opposite effect of protein synthesis inhibitors on potassium deficiency-induced apoptotic cell death in immature and mature neuronal cultures. J Neurochem. 1995;65:1395-1398.
41. -)-2-hexyl-N-methyl propargylamine. J Neuroscience Res. 1996;46:82-89.
42. Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr. 1995;125:777S-783S.
43. Lopez PF, Yan Q, Kohen L, Rao NA. Retinal pigment epithelial wound healing. Arch Ophthalmol. 1995;113:1437-1446.